Legacy Bridge’s AbbVie ABBV Stock Holding History

Legacy Bridge’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.9K	Hold	156	–	–	0.01%	220
2025 Q4	$35.6K	Buy	156 +152	+3,800%	+$34.6K	0.01%	216
2025 Q3	$927	Hold	4	–	–	﹤0.01%	303
2025 Q2	$743	Buy	+4	New	+$743	﹤0.01%	290
2023 Q1	–	Sell	-472	Closed	-$76.3K	–	296
2022 Q4	$76.3K	Buy	+472	New	+$72.4K	0.05%	179
2022 Q2	–	Sell	-10,222	Closed	-$1.66M	–	290
2022 Q1	$1.66M	Hold	10,222	–	–	0.97%	21
2021 Q4	$1.38M	Buy	10,222 +30	+0.3%	+$3.54K	0.72%	48
2021 Q3	$1.1M	Buy	10,192 +20	+0.2%	+$2.29K	0.63%	71
2021 Q2	$1.15M	Buy	10,172 +425	+4%	+$47.9K	0.65%	68
2021 Q1	$1.05M	Buy	9,747 +816	+9%	+$87.3K	0.68%	65
2020 Q4	$957K	Buy	8,931 +1,390	+18%	+$134K	0.69%	58
2020 Q3	$661K	Sell	7,541 -19	-0.3%	-$1.79K	0.6%	62
2020 Q2	$742K	Sell	7,560 -436	-5%	-$38.4K	0.82%	41
2020 Q1	$609K	Buy	7,996 +699	+10%	+$59.5K	0.77%	43
2019 Q4	$646K	Sell	7,297 -1,414	-16%	-$117K	0.54%	68
2019 Q3	$660K	Sell	8,711 -620	-7%	-$42.5K	0.63%	60
2019 Q2	$679K	Hold	9,331	–	–	0.65%	54
2019 Q1	$752K	Hold	9,331	–	–	0.78%	37
2018 Q4	$860K	Buy	+9,331	New	+$821K	1.06%	16

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Legacy Bridge's ABBV Position: Q1 2026 in Review

Legacy Bridge held its AbbVie (ABBV) position steady in Q1 2026 at 156 shares worth $33.9K. The position accounts for 0.01% of the portfolio, ranked #220.

Legacy Bridge first reported a position in ABBV in Q4 2018 and has held it in 19 quarters since. The position peaked at $1.66M in Q1 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Legacy Bridge held 156 shares of AbbVie worth $33.9K as of Q1 2026.
Legacy Bridge left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.01% of Legacy Bridge's portfolio in Q1 2026, its #220 holding.
Legacy Bridge first reported a position in AbbVie in Q4 2018 and has held it in 19 quarters since.
Legacy Bridge's AbbVie position peaked at $1.66M in Q1 2022.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Legacy Bridge's 13F filing for Q1 2026, filed 14 May 2026.